Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e156-e157. doi: 10.1111/jdv.15383. Epub 2019 Jan 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Alopecia Areata / drug therapy*
  • Female
  • Humans
  • Janus Kinases / antagonists & inhibitors
  • Middle Aged
  • Nitriles
  • Piperidines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Pyrroles / therapeutic use*
  • Recurrence
  • Withholding Treatment

Substances

  • Nitriles
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • Pyrroles
  • ruxolitinib
  • tofacitinib
  • Janus Kinases